Abstract 66: High-throughput screening using patient derived tumor cell to conduct personalized medicine
Seung T. Kim(Samsung Medical Center), Jiryeon Jang(Samsung Medical Center), Kyoung‐Mee Kim(Samsung (South Korea)), young park(Samsung Medical Center), Sun Kim(Seoul National University of Science and Technology), Joon Park(Sungkyunkwan University), Won Lee(Gachon University), Woong‐Yang Park(Samsung Medical Center), Charny Park(Samsung Medical Center), Jeeyun Lee(Samsung Medical Center)
Cited by 1
Related Papers
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|867
SARS-CoV-2 and Stroke in a New York Healthcare System
|Stroke|2020|751
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
Spatiotemporal Evolution of the Primary Glioblastoma Genome
|Cancer Cell|2015|320